RX0041-002
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RX0041-002, covering 2018-04-06 to 2018-04-06. Get the full timeline:
Most recent: Clinical Trial Update: PK Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Normal Renal Function [Phase 1]